Cite
HARVARD Citation
van Holten, J. et al. (2005). A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Annals of the rheumatic diseases. 64 (1), pp. 64-69. [Online].